Impax Laboratories, Inc.
Free In-Depth Equity Research Report
Impax Laboratories shares increased 2.17 percent to close at $24.06 a share Wednesday. The stock traded between $23.26 and $24.64 on volume of 4.26 million shares traded. Analysts at Cowen & Company have recently downgraded the company’s rating to “market perform” from “outperform”. Shares of Impax Laboratories have fallen approximately 4.0 percent year-to-date. Going forward ... (see research report)